Delineating the mechanism of Alzheimer's disease A beta peptide neurotoxicity - PubMed (original) (raw)

Review

Delineating the mechanism of Alzheimer's disease A beta peptide neurotoxicity

Roberto Cappai et al. Neurochem Res. 2008 Mar.

Abstract

The Alzheimer's disease neurotoxic amyloid-beta (A beta) peptide is derived from the larger amyloid precursor protein (APP) and is the principal component of the senile plaques in Alzheimer's disease (AD) brains. This mechanism by which A beta mediates neurotoxicity or neuronal dysfunction is not fully resolved. This review will outline some of the key determinants that modulate A beta's activity and the cellular pathways and mechanisms involved.

PubMed Disclaimer

Similar articles

• The toxic conformation of the 42-residue amyloid beta peptide and its relevance to oxidative stress in Alzheimer's disease.
  Irie K, Murakami K, Masuda Y, Morimoto A, Ohigashi H, Hara H, Ohashi R, Takegoshi K, Fukuda H, Nagao M, Shimizu T, Shirasawa T. Irie K, et al. Mini Rev Med Chem. 2007 Oct;7(10):1001-8. doi: 10.2174/138955707782110187. Mini Rev Med Chem. 2007. PMID: 17979802 Review.
• A mutation protective against Alzheimer's disease renders amyloid β precursor protein incapable of mediating neurotoxicity.
  Hashimoto Y, Matsuoka M. Hashimoto Y, et al. J Neurochem. 2014 Jul;130(2):291-300. doi: 10.1111/jnc.12717. Epub 2014 Apr 10. J Neurochem. 2014. PMID: 24646423
• Alzheimer's disease.
  De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV. De-Paula VJ, et al. Subcell Biochem. 2012;65:329-52. doi: 10.1007/978-94-007-5416-4_14. Subcell Biochem. 2012. PMID: 23225010 Review.
• Aβ promotes VDAC1 channel dephosphorylation in neuronal lipid rafts. Relevance to the mechanisms of neurotoxicity in Alzheimer's disease.
  Fernandez-Echevarria C, Díaz M, Ferrer I, Canerina-Amaro A, Marin R. Fernandez-Echevarria C, et al. Neuroscience. 2014 Oct 10;278:354-66. doi: 10.1016/j.neuroscience.2014.07.079. Epub 2014 Aug 26. Neuroscience. 2014. PMID: 25168729
• The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
  Savelieff MG, DeToma AS, Derrick JS, Lim MH. Savelieff MG, et al. Acc Chem Res. 2014 Aug 19;47(8):2475-82. doi: 10.1021/ar500152x. Epub 2014 Jul 31. Acc Chem Res. 2014. PMID: 25080056

Cited by

• [18F]ROStrace detects oxidative stress in vivo and predicts progression of Alzheimer's disease pathology in APP/PS1 mice.
  Hsieh CJ, Hou C, Zhu Y, Lee JY, Kohli N, Gallagher E, Xu K, Lee H, Li S, McManus MJ, Mach RH. Hsieh CJ, et al. EJNMMI Res. 2022 Jul 27;12(1):43. doi: 10.1186/s13550-022-00914-x. EJNMMI Res. 2022. PMID: 35895177 Free PMC article.
• Alzheimer's disease: ageing-related or age-related? New hypotheses from an old debate.
  Bugiani O. Bugiani O. Neurol Sci. 2011 Dec;32(6):1241-7. doi: 10.1007/s10072-011-0614-4. Epub 2011 May 13. Neurol Sci. 2011. PMID: 21567180
• Molecular dynamics simulation studies of the structural response of an isolated Aβ1-42 monomer localized in the vicinity of the hydrophilic TiO 2 surface.
  Jose JC, Sengupta N. Jose JC, et al. Eur Biophys J. 2013 Jun;42(6):487-94. doi: 10.1007/s00249-013-0900-6. Epub 2013 Apr 12. Eur Biophys J. 2013. PMID: 23579595
• Copper in the brain and Alzheimer's disease.
  Hung YH, Bush AI, Cherny RA. Hung YH, et al. J Biol Inorg Chem. 2010 Jan;15(1):61-76. doi: 10.1007/s00775-009-0600-y. Epub 2009 Oct 28. J Biol Inorg Chem. 2010. PMID: 19862561 Review.

References

1. 1. J Neurosci. 2004 May 12;24(19):4692-7 - PubMed
2. 1. J Neurochem. 2005 Nov;95(3):834-47 - PubMed
3. 1. FASEB J. 2001 Nov;15(13):2433-44 - PubMed
4. 1. Amino Acids. 1998;14(1-3):181-7 - PubMed
5. 1. Science. 2001 Aug 24;293(5534):1487-91 - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Ovid Technologies, Inc.
  • Springer

• Medical

  • MedlinePlus Health Information